Clinical and Transvaginal Sonographic Evaluation of the Prostate in Transsexual Women

Urology

Volumn 74, Issue 1, 2009, Pages 191-196

  Weyers, Steven ^a   Decaestecker, Karel ^a   Verstraelen, Hans ^a   Monstrey, Stan ^a   T'Sjoen, Guy ^a   Gerris, Jan ^a   Hoebeke, Piet ^a   Villeirs, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CALCIFICATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; FEASIBILITY STUDY; FEMALE; GYNECOLOGICAL EXAMINATION; GYNECOLOGY; HUMAN; PAIN; PALPATION; PERFORMANCE; PRIORITY JOURNAL; PROSTATE; RADIOLOGIST; SCAR; SEMINAL VESICLE; TRANSSEXUALISM; TRANSVAGINAL ECHOGRAPHY; UNIVERSITY HOSPITAL; VAGINA;

ADULT; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; PALPATION; PROSTATE; TRANSSEXUALISM; ULTRASONOGRAPHY; VAGINA;

EID: 67649224291     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.06.016     Document Type: Article

References (25)

1. Fisk N. Gender dysphoria syndrome (the how, what and why of the disease). In: Laub D., and Gandy P. (Eds). Proceedings of the Second Interdisciplinary Symposium on Gender Dysphoria Syndrome (1973), Stanford University Press, Palo Alto, CA 7-14
2. Meyer III W., Bockting W., Cohen-Kettenis P., et al. The Standards of Care for Gender Identity Disorders - Sixth Version. Int J Transgenderism 5 (2001). http://www.symposion.com/ijt/soc_2001/index.htm Accessed on March 18, 2009.
3. Markland C. Transsexual surgery. Ann Obstet Gynecol 4 (1974) 209-220
4. Thurston. Carcinoma of the prostate in a transsexual. Br J Urol 73 (1994) 217
5. Van Haarst E., Newling D., Gooren L., et al. Metastatic prostatic carcinoma in a male-to-female transsexual. Br J Urol 81 (1998) 776
6. Miksad A., Bubley G., Church P., et al. Prostate cancer in a transgender woman 41 years after initiation of feminization: Research letter. JAMA 296 (2006) 2316-2317
7. Dorff T.B., Shazer R.L., Nepomuceno E.M., et al. Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient. Clin Genitourin Cancer 5 (2007) 344-346
8. Goodwin W.E., and Cummings R.H. Squamous metaplasia of the verumontanum with obstruction due to hypertrophia: long-term effects of estrogen on the prostate in an aging male-to-female transsexual. J Urol 131 (1984) 553-554
9. Yokoyama M., Seki N., Tamai M., et al. Benign prostatic hyperplasia in a patient castrated in his youth. J Urol 142 (1998) 134-135
10. Brown J.A., and Wilson T.M. Benign prostatic hyperplasia requiring transurethral resection of the prostate in a 60-year-old male-to-female transsexual. BJU Int 80 (1997) 956-957
11. Casella R., Bubendorf L., Schaefer D.J., et al. Does the prostate really need androgens to grow?. Transurethral resection of the prostate in a male-to-female transsexual 25 years after sex-changing operation. Urol Int 75 (2005) 288-290
12. Wilson J.D., and Roehrborn C. Long-term consequences of castration in men: Lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. J Clin Endocrinol Metab 84 (1999) 4324-4331
13. Van Kesteren P., Meinhardt W., van der Valk P., et al. Effects of estrogens only on the prostates of aging men. J Urol 156 (1996) 1349-1353
14. Jin B., Turner L., Walters W.A.W., and Handelsman D.J. Androgen or estrogen effect on human prostate. J Clin Endocrinol Metab 81 (1996) 4290-4295
15. Kuhn A., Hiltebrand R., and Birkhäuser M. Do transsexuals have micturition disorders?. Eur J Obstet Gynecol Reprod Biol 131 (2007) 262-230
16. Feldhamer L., Grimmond A., and Gerard P. Transvaginal sonographic evaluation of prostatitis in a transsexual. J Diagn Med Sonography 9 (1993) 73-75
17. Zackrisson B., Hugosson J., and Aus G. Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men. Scand J Urol Nephrol 34 (2000) 175-180
18. Geller J. Non-surgical treatment in prostatic hyperplasia. Cancer 70 (1992) 339-345
19. Geller J., and Sionit L. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride. J Cell Biochem Suppl 16H (1992) 109-112
20. Sharifi N., Gulley J.L., and Dahut W.L. Androgen deprivation therapy for prostate cancer. JAMA 294 (2005) 238-244
21. Geller J. Overview of benign prostatic hypertrophia. Urology 34 (1989) 57-63
22. Ho S.M. Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91 (2003) 491-503
23. Roehrborn C., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1983) 581-589
24. Oesterling J.E., Jacobsen S.J., Chute C.H., et al. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270 (1993) 860-864
25. Ilic D., O'Connor D., Green S., et al. Screening for prostate cancer: A Cochrane systematic review. Cancer Causes Control 18 (2007) 279-285